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entitled “Substrate topography: A valuable in vitro tool, but a
clinical red herring for in vivo tenogenesis” [1]. We report mea-
surements on tenocyte viability, metabolic activity and prolifera-
tion on substrates with different topographies. We also report the
effect of substrates with different topographies on host cells in a
subcutaneous model.
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ype of data Figures
ow data was acquired in vitro assays; in vivo assays
ata format Analysed data
xperimental factors Substrates with various topographies
xperimental features in vitro and in vivo data
ata source location Galway, Ireland
ata accessibility Data are supplied in this articleValue of the data: Two-dimensional substrates, with appropriate topographical features and rigidity, may be used to
maintain cell phenotype ex vivo.
 Two-dimensional substrates, with sub-micron to low micron features, may not be suitable for
directional neotissue formation in vivo.
 Three-dimensional constructs may be more effective tools for directional neotissue formation
in vivo.
1. Data
Herein, we assessed tenocyte viability, metabolic activity and proliferation on substrates with
different topographies. The substrates were poly(lactic-co-glycolic acid) (PLGA) based with constant
groove and line width of 1911.42737.50 nm and 2101.78735.21 nm respectively and variable groove
depth of 37.4873.4 nm, 317.2977.05 nm and 1988.27195.3 nm. Non-imprinted substrates were
used as control. We also assessed these these substrates in a subcutaneous model.2. Experimental design, materials and methods
2.1. Human tenocyte viability, metabolic activity and proliferation
Live/Deads assay (BioSource International, Invitrogen, Ireland) was performed on days 1, 5 and 10
to assess cellular viability, as per manufacturer's protocol. Briefly, cells were washed 3 times with
HBSS and exposed to the staining solution of calcein and ethidium homodimer. The cells were
incubated at 37 °C for 45 min. Following staining, the cells were viewed using the BX51 Olympus
fluorescence microscope and analysed using ImageJ.
Cell metabolic activity was determined using alamarBlues assay on days 1, 5, and 10, as per
manufacturer's protocol. Briefly, alamarBlues dye was diluted with HBSS to make a 10% (v/v) ala-
marBlues solution. Media was removed from each well and 0.5 ml alamarBlues solution was added
to each well. Cell were incubated for 3 h at 37 °C; the absorbance of the alamarBlueswas measured at
wavelengths of 550 nm and 595 nm using a microplate reader (Varioskan Flash, Thermo Scientific,
UK). The level of metabolic activity was calculated using the simplified method of calculating %
reduction, according to the supplier’s protocol.
Cell proliferation was assessed on days 1, 5, and 10, by counting DAPI stained cell nuclei, using the
BX51 Olympus fluorescence microscope.
All experiments (viability, metabolic activity and proliferation) were repeated in three indepen-
dent experiments and each experiment was performed in triplicate.
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The Animal Care Research Ethics Committee of NUI Galway approved all experimental protocols.
For the subcutaneous study, female Lewis rats (200–250 g) were used, following a protocol described
previously [2]. Briefly, surgery was performed on rats under general anaesthesia. Incisions were made
at the back of each animal, allowing insertion of a 0.5 cm0.5 cm structured substrate. The wound
was then closed, using biodegradable sutures. Following euthanisation, the substrates were harvested
at days 2 and 14 and were stained using DAPI and rhodamine conjugated phalloidin. Three animals
were used per time point and at each animal all three structured substrates were implanted. Images
were captured with an Olympus IX-81 inverted microscope (Olympus Corporation, Tokyo, Japan).
3. Results
Figs. 1 and 2.0 
20 
40 
60 
80 
100 
120 
Day 1 Day 5 Day 10
Day 1 Day 5 Day 10
Day 1 Day 5 Day 10
C
el
l V
ia
bi
lit
y
(L
iv
e/
D
ea
d®
)
Control 
37 nm 
317 nm 
1988 nm 
Control 
37 nm 
317 nm 
1988 nm 
Control 
37 nm 
317 nm 
1988 nm 
0 
20 
40 
60 
80 
100 
120 
140 
%
C
el
l M
et
ab
ol
ic
 A
ct
iv
ity
(a
la
m
ar
B
lu
e®
)
0 
50 
100 
150 
200 
250 
300 
350 
C
el
l P
ro
lif
er
at
io
n
(C
el
l N
um
be
r /
 m
m
2 )
Fig. 1. Tenocyte viability, metabolic activity and proliferation as a function of substrate topography and time in culture. No
significant differences were detected.
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Fig. 2. Microscopic images of host cells on substrates with different topographies. Nuclei were stained blue with DAPI and
cytoskeleton was stained red with rhodamine-conjugated phalloidin. Substrate topography did not affect host cell orientation.
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